Literature DB >> 8209753

Evolution and tropism of transmissible gastroenteritis coronavirus.

L Enjuanes1, C Sánchez, F Gebauer, A Méndez, J Dopazo, M L Ballesteros.   

Abstract

Transmissible gastroenteritis coronavirus (TGEV) is an enteropathogenic coronavirus isolated for the first time in 1946. Nonenteropathogenic porcine respiratory coronaviruses (PRCVs) have been derived from TGEV. The genetic relationship among six European PRCVs and five coronaviruses of the TGEV antigenic cluster has been determined based on their RNA sequences. The S proteins of six European PRCVs have an identical deletion of 224 amino acids starting at position 21. The deleted area includes the antigenic sites C and B of TGEV S glycoprotein. Interestingly, two viruses (NEB72 and TOY56) with respiratory tropism have the S protein with a similar size to the enteric viruses. NEB72 and TOY56 viruses have 2 and 15 specific amino acid differences with the enteric viruses, respectively. Four of the residues changed are located within the deletion present in the PRCVs and may influence the enteric tropism of TGEV in vivo. A receptor binding site (RBS) used by the virus to infect ST and other cell types might be located between sites A and D of the S glycoprotein, since monoclonal antibodies (MAbs) specific for these sites inhibit the binding of the virus to ST cells. An evolutionary tree relating 13 enteric and respiratory isolates has been proposed. According to this tree, a main virus lineage evolved from a recent progenitor which was circulating around 1941. From this, secondary lineages originated PUR46, NEB72, TOY56, MIL65, BRI70, and the PRCVs, in this order. Least squares estimation of the origin of TGEV-related coronaviruses showed a significant constancy in the mutation fixation rate.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8209753     DOI: 10.1007/978-1-4615-2996-5_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

1.  Function of a 5'-end genomic RNA mutation that evolves during persistent mouse hepatitis virus infection in vitro.

Authors:  W Chen; R S Baric
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

Review 2.  Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competence.

Authors:  Taylor Heald-Sargent; Tom Gallagher
Journal:  Viruses       Date:  2012-04-12       Impact factor: 5.048

3.  Cells of human aminopeptidase N (CD13) transgenic mice are infected by human coronavirus-229E in vitro, but not in vivo.

Authors:  David E Wentworth; D B Tresnan; B C Turner; I R Lerman; B Bullis; E M Hemmila; R Levis; L H Shapiro; Kathryn V Holmes
Journal:  Virology       Date:  2005-05-10       Impact factor: 3.616

4.  Delineation and modelling of a nucleolar retention signal in the coronavirus nucleocapsid protein.

Authors:  Mark L Reed; Brian K Dove; Richard M Jackson; Rebecca Collins; Gavin Brooks; Julian A Hiscox
Journal:  Traffic       Date:  2006-05-25       Impact factor: 6.215

5.  A double epidemic model for the SARS propagation.

Authors:  Tuen Wai Ng; Gabriel Turinici; Antoine Danchin
Journal:  BMC Infect Dis       Date:  2003-09-10       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.